• Similar Symptoms Found in Scleroderma Patients in the U.S., Regardless of Their Immunosuppressant Use, Study Finds
  • Cantargia Starts Development of CAN10 Antibody for Scleroderma, Myocarditis
  • Galapagos Completes Enrollment in Phase 2a Trial Testing GLPG1690 in Diffuse Cutaneous Scleroderma
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • Bob Saget to Host Annual Cool Comedy – Hot Cuisine Event to Benefit Scleroderma Research Foundation
  • Antibody CD45-ADC Shows Potential to Treat Scleroderma and Other Diseases in Mice, Study Shows
  • Health Canada Approves Ofev to Help Preserve Lung Health in People with SSc-ILD
  • Cardiopulmonary Exercise Testing May Help Detect PAH in Scleroderma Patients, Study Suggests
  • Advanced Ultrasound of Skin May Best Determine Scleroderma Activity and Progression, Study Suggests
  • Lenabasum Shows Sustained Efficacy in Patients with Diffuse Cutaneous Scleroderma, Extension Study Finds
  • Rare Disease Film Festival Highlights Patient and Researcher Unity
  • Black Patients with Scleroderma Experience Faster Disease Progression and Higher Mortality than Whites and Asians, Study Finds